Clinical efficacy and safety: cardiovascular system

The European Medicines Agency's scientific guidelines on the clinical evaluation of human medicines used in conditions affecting the cardiovascular system help medicine developers prepare marketing authorisation applications.

If you have comments on a document which is open for consultation, use the Microsoft Office document iconform for submission of comments on scientific guidelines .

Please submit your comments to the following email address: cvswpsecretariat@ema.europa.eu.

For a complete list of scientific guidelines currently open for consultation, see Public consultations.


Hypertension

Guidelines


Lipid disorders

Guidelines


Pulmonary arterial hypertenstion

Guidelines


Arrythmias

Guidelines


Venous thromboembolism

Guidelines

Concept papers


Heart failure

Guidelines


Coronary artery disease

Guidelines


Other

Guidelines


Reflection papers


Position statements

How useful was this page?

Add your rating